These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 13706884)

  • 1. [The coenzyme role of phospho-5-pyridoxal. Glutamic-aspartic transaminase and cyclic hydrazides].
    GONNARD P; NGUYEN-PHILIPPON C
    Bull Soc Chim Biol (Paris); 1961; 43():601-7. PubMed ID: 13706884
    [No Abstract]   [Full Text] [Related]  

  • 2. [The coenzyme role of hydrazones for phospho-5-pyridoxal kynureniase and cyclic hydrazides].
    GONNARD P; BOIGNE N
    Bull Soc Chim Biol (Paris); 1961; 43():609-17. PubMed ID: 13726648
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological antagonism between pyridoxal 5-phosphate (activator of DOPA decarboxylase) and certain hydrazines (inhibitors of monoamine oxidase)].
    LEVY J; MICHEL-BER E
    C R Hebd Seances Acad Sci; 1960 Jun; 250():4061-3. PubMed ID: 14416402
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of thyroxine on alanine-glutamic and aspartic-glutamic transaminase of rat liver; a preliminary report.
    HORVATH A
    Enzymologia; 1958 Jun; 19(5):297-302. PubMed ID: 13574108
    [No Abstract]   [Full Text] [Related]  

  • 5. The site of binding of pyridoxal-5'-phosphate to heart glutamic-aspartic transaminase.
    HUGHES RC; JENKINS WT; FISCHER EH
    Proc Natl Acad Sci U S A; 1962 Sep; 48(9):1615-8. PubMed ID: 14449825
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on glutamic-oxalacetic transaminase. II. The properties of two derivatives of pyridoxal 5-phosphate.
    BONAVITA V; SCARDI V
    Arch Biochem Biophys; 1959 Jun; 82(2):300-9. PubMed ID: 13661954
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glutamic-oxalacetic transaminase in the liver of diabetic subjects].
    PAGLIARO L; NOTARBARTOLO A
    Boll Soc Ital Biol Sper; 1961 Apr; 37():335-7. PubMed ID: 13732068
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the coenzyme activation of glutamic-aspartic apotransaminase.
    MEISTER A; SOBER HA; PETERSON EA
    J Biol Chem; 1954 Jan; 206(1):89-100. PubMed ID: 13130530
    [No Abstract]   [Full Text] [Related]  

  • 9. [ASPARTATE-GLUTAMATE-APOTRANSAMINASE INTERACTIONS WITH PYRIDOXAL PHOSPHATE AND CERTAIN OF ITS DERIVATIVES].
    TORCHINSKII IuM
    Biokhimiia; 1963; 28():731-40. PubMed ID: 14068590
    [No Abstract]   [Full Text] [Related]  

  • 10. Glutamic-aspartic transaminase. VI. The reaction with certain beta-substituted aspartic acid analogues.
    JENKINS WT
    J Biol Chem; 1961 Apr; 236():1121-5. PubMed ID: 13789845
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of isoniazid on glycide matabolism. VIII. On the effect of isoniazid and hydrazine hydrochloride on the glutamic acid and aspartic acid content of the rat liver].
    KRULIK R
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1962; 126():35-7. PubMed ID: 13927108
    [No Abstract]   [Full Text] [Related]  

  • 12. Convulsant hydrazides. I. In vitro and in vivo inhibition of vitamin B6 enzymes by convulsant hydrazides.
    KILLAM KF; BAIN JA
    J Pharmacol Exp Ther; 1957 Feb; 119(2):255-62. PubMed ID: 13417077
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of aspartic acid and glutamic acid hydrazides on Mycobacterium tuberculosis. I. Effect of aspartic acid hydrazide on Mycobacterium tuberculosis cultures].
    MASSALSKI W; ODRZYWOLSKA A; MIGDALSKA B; DABROWSKA H
    Gruzlica (1926); 1958 Nov; 26(11):919-26. PubMed ID: 13630439
    [No Abstract]   [Full Text] [Related]  

  • 14. [Processes of tissular transamination & pharmacological lesions due to radiomimetic substances. I. Hepatic & splenic aspartic glutamic transaminases].
    SALGARELLO G; MORATELLO R; MURARI G
    Boll Soc Ital Biol Sper; 1958 Nov; 34(22):1540-3. PubMed ID: 13607853
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coenzyme activity of 2-(2-methyl-3-hydroxy-4-pyridyl-5-methylphosphoric)-4-thiazolidinecarboxylic acid].
    Haertelt M; Angeletti E
    Boll Chim Farm; 1965 Oct; 104(10):642-7. PubMed ID: 5881380
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver glutamic-aspartic transaminase activity in diabetes.
    PATRICK SJ; TULLOCH JA
    Lancet; 1959 Apr; 1(7076):757-9. PubMed ID: 13642877
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glutamic acid-oxalacetic acid transaminase determinations in human liver tissue].
    PIETSCHMANN H; WIEDERMANN G
    Wien Z Inn Med; 1959 Dec; 40():455-60. PubMed ID: 14432908
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between chronaximetric excitability and the glutamic-oxalacetic transaminase contents of antagonist muscles.
    DOROGAN D; FAIGHELIS C; BATCU A
    Rum Med Rev; 1961; 5():143-4. PubMed ID: 13723953
    [No Abstract]   [Full Text] [Related]  

  • 19. Glutamic-oxaloacetic transaminase in semen of human, bull, and rabbit seminal plasma.
    GREGOIRE AT; RAKOFF AE; WARD K
    Int J Fertil; 1961; 6():73-8. PubMed ID: 13708396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of large doses of pyramidon on glutamic-oxalic transaminase activity in the liver and kidneys].
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Kiserl Orvostud; 1961 Mar; 13():82-5. PubMed ID: 13698455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.